Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 20Gastrointestinal 5Lymphoid 4Other hematologic neoplasm 3Plasma cell 2Gynecologic 2Breast 2Head & Neck 1Genitourinary 1

Conditions

Head and Neck Neoplasms 330Nasopharyngeal Carcinoma 223Squamous Cell Carcinoma of Head and Neck 205Thyroid Neoplasms 123Mouth Neoplasms 70Nasopharyngeal Neoplasms 55Thyroid Nodule 52Oropharyngeal Neoplasms 42Laryngeal Neoplasms 42Breast Neoplasms 42Neoplasms 33Neoplasm Metastasis 29Thyroid Cancer, Papillary 28Lung Neoplasms 27Hypopharyngeal Neoplasms 27Colorectal Neoplasms 26Carcinoma, Non-Small-Cell Lung 25Esophageal Neoplasms 23Recurrence 22Pancreatic Neoplasms 22Stomach Neoplasms 21Carcinoma, Squamous Cell 21Thyroid Diseases 20Prostatic Neoplasms 19Stomatitis 18Ovarian Neoplasms 18Salivary Gland Neoplasms 17Melanoma 17Uterine Cervical Neoplasms 15Radiation Injuries 15

Interventions

iron isomaltoside 1000 1Radiotherapy, Intensity-Modulated 1Niferex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Anemia × Head & Neck × Clear all
NCT05913414 2023-06-22

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Unknown
120 enrolled
Classical hematologyHead & Neck

Nasopharyngeal Carcinoma, Anemia, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡